Randomized phase III trial of low-molecular-weight heparin enoxaparin in addition to standard treatment in small-cell lung cancer: the RASTEN trial
Journal article published in 2018 by
L. Ek,
E. Gezelius,
B. Bergman,
P. O. Bendahl,
H. Anderson,
J. Sundberg,
M. Wallberg,
U. Falkmer,
S. Verma,
M. Belting 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 